Opportunities to Optimize Lifestyle Interventions in Combination With GLP-1 Receptor Agonist Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Opportunities to optimize lifestyle interventions in combination with glucagon-like peptide-1-based therapy
Diabetes Obes Metab 2024 Sep 01;26 Suppl 4(2024)3-15, S DashFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.